336. A PHASE 2, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO TEST THE EFFICACY AND SAFETY OF MAVRILIMUMAB IN GIANT CELL ARTERITIS: STUDY DESIGN AND METHODOLOGY | Zendy

AI Assistant Blog Pricing

336. A PHASE 2, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO TEST THE EFFICACY AND SAFETY OF MAVRILIMUMAB IN GIANT CELL ARTERITIS: STUDY DESIGN AND METHODOLOGY

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.